Medical and dialytic management of hyperkalemia in hemodialysis patients

被引:3
作者
Allon, M
机构
[1] UNIV ALABAMA,CTR NEPHROL RES & TRAINING,BIRMINGHAM,AL 35294
[2] VET ADM MED CTR,BIRMINGHAM,AL
关键词
D O I
10.1177/039139889601901203
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:697 / 699
页数:3
相关论文
共 17 条
[11]  
GUTTIEREZ R, 1991, MINER ELECTROLYTE ME, V17, P297
[12]  
LENS XM, 1989, NEPHROL DIAL TRANSPL, V4, P228
[13]  
LIOU HH, 1994, AM J KIDNEY DIS, V26, P266
[14]   POTASSIUM-LOWERING EFFECT OF ALBUTEROL FOR HYPERKALEMIA IN RENAL-FAILURE [J].
MONTOLIU, J ;
LENS, XM ;
REVERT, L .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) :713-717
[15]   VARIABILITY IN POTASSIUM REMOVAL BY HEMODIALYSIS [J].
SHERMAN, RA ;
HWANG, ER ;
BERNHOLC, AS ;
EISINGER, RP .
AMERICAN JOURNAL OF NEPHROLOGY, 1986, 6 (04) :284-288
[16]   HEMODIALYSATE COMPOSITION AND INTRADIALYTIC METABOLIC, ACID-BASE AND POTASSIUM CHANGES [J].
WARD, RA ;
WATHEN, RL ;
WILLIAMS, TE ;
HARDING, GB .
KIDNEY INTERNATIONAL, 1987, 32 (01) :129-135
[17]  
WILLIAMS AJ, 1984, P EUR DIAL T ASS, V21, P209